Peran Apoteker Dalam Peningkatan Mutu dan

Peran Apoteker Dalam Peningkatan Mutu dan Keselamatan
Pasien Untuk Meningkatkan Produktivitas dan Efisiensi
Rumah Sakit
Dra. Yulia Trisna, Apt., M.Pharm
Rumah Sakit :
Quality, Safety, Cost
Biaya
Kemajuan teknologi
VS
Keterbatasan sumber daya
Kemajuan teknologi
„health
gap“
Sumber daya
Waktu
MUTU
KEAMANAN
OBAT
BIAYA
KHASIAT
Pemilihan Obat
AFFORDABILITY
QUALITY
EFFICACY
SAFETY
COST
EFFECTIVENESS
What Hospital Pharmacists Do
Courtesy of European Association of Hospital Pharmacists
PENGELOLAAN OBAT
PEMANFAATAN TEKNOLOGI INFORMASI
ELECTRONIC PRESCRIBING:
• Meningkatkan keselamatan pasien
• Mempercepat pelayanan
• Mempercepat proses tagihan
AUTOMASI PENYIAPAN OBAT
Automated Dispensing Cabinet
PRODUKSI DAN ASEPTIC DISPENSING
Robotic I.V. Admixture
FARMASI KLINIK
Wawancara
Riwayat Penggunaan Obat
Monitoring Terapi Obat
Pelayanan
Informasi Obat
Visite
Pengkajian Resep
Konseling Obat
Peran Farmasi RS meningkatkan keselamatan pasien
Admission medication history
Allergy check
Prescribing protocols
Formulary
Medication review
Drug distribution system
Administration instructions
Drug therapy monitoring
•Adapted by P.Thornton from J. Reason, 9/01
Manfaat Ekonomi Pelayanan Farmasi Klinik
Pharmacotherapy 2014; 34(8): 771-793
Dampak Ekonomi dari Pelayanan Farmasi Klinik

Chisholm-Burns MA, Zivin JSG, Lee JK, et al. Economic effects of pharmacists on
health outcomes in the United States: A systematic review. Am J Health-Syst Pharm,
2010; 67:1624-34

MacLaren R, Bond CA, Martin SJ, Fike D. Clinical and economic outcomes of
involving pharmacists in the direct care of critically ill patients with infections. Crit
Care Med 2008;36:3184–9.

Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse
events prevented by interventions of a critical care pharmacist. Am J Health Syst
Pharm 2007;64:2483–7.

Zaidi ST, Hassan Y, Postma MJ, Ng SH. Impact of pharmacist recommendations on
the cost of drug therapy in ICU patients at a Malaysian hospital. Pharm World Sci
2003;25:299–302.

Gandhi PJ, Smith BS, Tataronis GR, et al. Impact of a pharmacist on drug costs in
a coronary care unit. Am J Health Syst Pharm 2001;58:497–503.
Non-value
added/waste
Value
added
Sebelum Lean
Setelah Lean
(Am J Health-Syst Pharm. 2017;73: 958-61)
TERIMA KASIH